Expert consensus on disease-modifying therapies in MS

[MSUK]

A growing body of evidence suggests that early control of disease activity in patients with multiple sclerosis (MS) plays a key role in preventing disability, prolonging the period of being active and engaged, and protecting quality of life.

For that reason, MS experts are calling for early and full access to all disease-modifying therapies (DMTs) for patients with MS...... Read more - http://www.ms-uk.org/drugsresearch